UBS Group »

Rigel Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.8M 101k 28.33
2025-06-30 $1.3M 68k 18.73
2025-03-31 $840k 47k 17.99
2024-12-31 $230k 14k 16.82
2024-09-30 $149k 9.2k 16.18